Momelotinib, an oral pill taken once a day, significantly improved outcomes of patients treated for myelofibrosis (MF), a rare but fatal bone marrow cancer, researchers reported June 7. Ruben Mesa, MD, FACP, executive director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, presented results of the MOMENTUM phase 3 randomized […]

Paymon Bagheri has joined the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, as the senior director of finance and administration. Paymon is a Fellow of the American College of Healthcare Executives (FACHE), Fellow of the American College of Medical Practice Executives (FACMPE) and a certified Lean Six Sigma health […]

The Mays Cancer Center at UT Health San Antonio and local partner Evestra Inc. have been awarded a five-year, $3.3 million Academic Industry Partnership grant from the National Institutes of Health (NIH). It is the first grant of this kind awarded to UT Health San Antonio.

Researchers at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), reporting this week in the journal Proceedings of the National Academy of Sciences, identified a mechanism through which two antiviral genes, when mutated, promote a childhood cancer called pediatric myelodysplastic syndrome (MDS). Scientists at Oklahoma State University and Cornell University collaborated […]